Congress trades in Regeneron Pharmaceuticals, Inc. (REGN)
7 of the members we track disclosed 12 purchases of REGN between 2022-05-05 and 2026-03-27, and 18 sales. Here is what the stock did afterwards.
Every purchase is measured over the three months after the transaction date, against XLV — the ETF standing in for Healthcare & Pharma — over exactly the same dates. The second figure is the one that carries information: the first mostly reflects what the sector did. How REGN was classified.
How these buys are tagged
3 of these purchases were made by a member whose own committee oversees Healthcare & Pharma. 2 are marked Cluster: A buy is marked Cluster when at least one other tracked member of Congress bought the same stock within 30 days of it, regardless of committee membership.
| Buys | Number | Return after 3 months | vs. sector | Beat their sector |
|---|---|---|---|---|
| All buys | 12 | -2.7% | -3.9% | 25% |
| Notable (committee-flagged) | 3 | Too few buys to measure | ||
| Unaligned (no committee overlap) | 9 | +0.5% | -0.5% | 33% |
| Cluster, excl. mega-caps | 2 | Too few buys to measure | ||
| Not clustered, excl. mega-caps | 10 | -5.4% | -7.0% | 10% |
Who bought the most
- Josh Gottheimer — 5 buys
- Jonathan L. Jackson — 2 buys
- Alan Armstrong — 1 buy
- Julia Letlow — 1 buy
- Gilbert Ray Cisneros, Jr. — 1 buy
Every disclosed purchase
| Member | Bought disclosed |
Signal | Price | 1W | 1M | 3M | vs sector |
|---|---|---|---|---|---|---|---|
| Alan Armstrong | 2026-03-27 2026-07-21 |
Notable | $737.71 | +3.3% | +1.9% | -14.2% | -26.1% |
| Julia Letlow | 2026-02-12 2026-03-12 |
Notable | $783.65 | -0.2% | -4.8% | -9.0% | -3.0% |
| Gilbert Ray Cisneros, Jr. | 2025-11-18 2025-12-15 |
Unaligned | $725.34 | +8.5% | +3.2% | +9.4% | +6.3% |
| Julie Johnson | 2025-01-15 2025-02-12 |
Unaligned | $703.43 | -3.3% | -4.2% | -21.9% | -18.9% |
| Jonathan L. Jackson | 2024-01-17 2024-02-15 |
Unaligned | $929.13 | +2.1% | +2.0% | -3.0% | -2.3% |
| Josh Gottheimer | 2023-08-21 2023-09-16 |
Unaligned | $844.37 | -1.6% | -1.5% | -5.1% | -1.6% |
| Josh Gottheimer | 2023-07-11 2023-08-21 |
Unaligned Cluster | $716.83 | +1.4% | +10.6% | +16.5% | +15.7% |
| Jonathan L. Jackson | 2023-06-23 2023-07-07 |
Unaligned Cluster | $779.73 | -7.8% | -5.8% | +5.8% | +7.2% |
| Tommy Tuberville | 2023-04-03 2023-05-12 |
Notable | $826.19 | -0.3% | -2.8% | -13.1% | -13.6% |
| Josh Gottheimer | 2022-10-19 2022-11-10 |
Unaligned | $709.37 | +3.5% | +3.9% | +2.1% | -4.3% |
| Josh Gottheimer | 2022-09-12 2022-10-16 |
Unaligned | $710.74 | +0.6% | +2.4% | +4.5% | -1.7% |
| Josh Gottheimer | 2022-05-05 2022-06-16 |
Unaligned | $639.37 | -0.8% | -1.4% | -3.8% | -4.8% |
Prices are the closing price on the transaction date, not what was paid: filings never disclose an execution price. Blank figures mean the window has not elapsed yet. Sales are not scored — a sale closes a position rather than opening one — so the 18 disclosed sales of REGN are not in this table.
Download the data behind this page, or read how every figure is calculated. Trades in REGN are a small part of the full rankings, which score each member across everything they bought.
Data last updated .